ÂÜÀòÂÒÂ×

Charles McOsker is the current Chief Scientific Officer at Clarametyx Biosciences, Inc. Prior to this, they served as the Chief Technical Operations Officer at BioMotiv from October 2018 to December 2019. From December 2012 to February 2017, they were the Vice President Technical Operations at BioMotiv LLC. Charles has also worked as a pharmaceutical consultant at Myoposity Therapeutics from January 2011 to December 2012 and as the CEO of Airway Therapeutics from October 2008 to December 2010. Charles McOsker began their career in 1983 as an Associate Director at P&G Pharmaceuticals and worked there until 2006.

Charles McOsker, PhD, is a biochemist and molecular biologist who earned their doctorate from Cornell University. Charles also holds a bachelor's degree in chemistry from Hope College.

They are on a team with James Rogers, PhD - Director, Program Operations, Veronica Hall, PhD - Chief Operating Officer. Their manager is David V. Richards, Chief Executive Officer.